Progressive Care
Launches Opioid Alternative Treatment
Campaign Aimed at
Reaching Millions Affected by
the Nationwide Epidemic
MIAMI, FL. -- June
12, 2018 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD),
a personalized
healthcare
services and technology company,
today launched
a new
program designed
to
educate patients and providers on treatment
alternatives
to opioids available through the company. The
campaign is part of the company's initiative
to
spread
awareness of available
alternative
therapies that can improve a person's quality of life and, in many
cases, prevent tragedy caused
by opioid abuse and
solve the nationwide epidemic.
Beginning
this
month and
running in digital and social properties, the
campaign is targeted to physicians and patients who have been
affected by the opioid epidemic and/or interested in receiving pain
management information. The campaign is estimated
to reach 20,000
patients
and physicians.
"As
one of the few providers in the nation that offers customized opioid alternative solutions
for
patients, as well as educates physicians on the current best
pain management medicinal therapies
and
custom compound
therapies,
Progressive Care has a large
opportunity
to
help alleviate
the
U.S. opioid epidemic," said S. Parikh Mars, CEO of Progressive
Care. "It is a serious issue and continues to cause incredible
damage to patients and communities through tragic overdose,
detrimental addictive behavior, and increased infectious disease
rates. We hope that this program
illustrates
Progressive Care's commitment to educating the public on the facts
of opioid alternatives and combat this growing problem
through
available
alternative
treatments."
Backed
by research statistics, the
campaign
features declarative
statements about
the misuse of opioids and
the
series of options and alternatives for patients and doctors to
consider before prescribing an opioid or for patients whose opioid
regimen is ineffective or causing harm. Mars continued: "Through
our experienced staff and on-site compounding lab capable of
producing both custom oral and topical dosage forms, Progressive
Care is in a position to make a real difference in patient health
outcomes by not only providing necessary information but also by
being a one-stop option for prescription management, especially
with therapies and treatments for pain."
Progressive
Care's wholly owned subsidiary, PharmCo, LLC has
the most current pharmacological information, a team
of pharmacists and technicians highly
trained
in pain management and compounding, and
offers physician in-services, educational seminars, patient
consultation and customized medicinal pain management
solutions.
The
company worked with Mass Ventures Corp,
a Florida-based
consulting agency providing app logistics, website production and
digital marketing, to
develop the program.
To
learn more about the campaign and
this program,
please
visit the company's website.
Connect
and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB:
RXMD),
through its PharmCo, LLC, is a South Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking
Statements
Statements contained herein that are not based upon current
or historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target," "intend" and "expect" and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject
to a number of risks, uncertainties, and other
factors that could cause the Company's actual results, performance,
prospects, and opportunities to differ materially from those
expressed in, or implied by, these forward-looking
statements.
Public Relations Contact:
Tory Patterson,
CMW Media
Tory@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024